Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-206P is a human pseudogene related to the U6 small nuclear RNA family, which are critical components of the spliceosome—the complex responsible for pre-mRNA splicing[1][3][5]. Unlike canonical U6 snRNA, which is highly conserved and functionally essential for spliceosome activity and gene expression regulation, pseudogene copies like RNU6-206P lack coding ability and are not known to be transcribed into functional RNAs. Pseudogene formation in the U6 family has been attributed to retrotransposition and template switching mechanisms[5][7]. Although U6 pseudogenes can sometimes be transcribed or have regulatory influence, RNU6-206P is not implicated in any biological process, disease role, or therapeutic targeting[2][7][9]. Their presence in the genome mainly reflects evolutionary processes and retrotransposon dynamics[7][9]. In summary: RNU6-206P is a non-coding RNA pseudogene, not a therapeutically relevant molecule, receptor, or biological target. It appears in gene databases due to its relationship to the U6 snRNA family, but does not serve as a functional protein/RNA nor a drug target and its mention within target lists likely reflects misclassification or confusion between functional and pseudogene copies[2][7][9].
None. There are no drugs or mechanisms targeting this molecule
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 206, pseudogene (RNU6-206P).